已收盘 08-01 16:00:00 美东时间
+0.030
+0.33%
Gilead Sciences (($GILD)), Arcus Biosciences (($RCUS)), Gilead Sciences (($CC:G...
今天 00:23
Arcus Biosciences (($RCUS)) announced an update on their ongoing clinical study...
今天 00:22
Gilead Sciences (($GILD)), Arcus Biosciences (($RCUS)), Gilead Sciences (($CC:G...
07-25 00:29
Arcus Biosciences (NYSE:RCUS) said on Thursday that its experimental drug candidate, quemliclustat, has received orphan drug status from the U.S. FDA. Quemliclustat is a type of medication that works ...
07-10 22:24
Arcus Biosciences ( ($RCUS) ) has provided an update. On June 1, 2025, Arcus Bi...
06-02 20:45
Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor, showed a confirmed overall response rate (ORR) of 46% in patients who reached a minimum of 12 weeks (two scans) of
06-02 14:52
(转自:医趋势) 5月13日,葛兰素史克(GSK)宣布停止开发TIGIT抗体药物belrestotug。仅在终止与GSK合作的TIGIT候选药物两周后,5月...
05-30 11:10
潜在涨幅754.7%!HC Wainwright & Co.:Alector获机构升目标价至10美元,维持"买入"评级
05-10 10:00
Goldman Sachs analyst Salveen Richter maintains Arcus Biosciences (NYSE:RCUS) with a Neutral and lowers the price target from $15 to $13.
05-08 22:50
Shares of ThredUp Inc. (NASDAQ:TDUP) rose sharply in today's pre-market trading...
05-06 17:28